Dave Marver

CEO

ONWARD Medical NV

Revolutionary Therapies for People with SCI

ONWARD Medical NV CEO, Dave Marver, will deliver a lecture on the company’s efforts to develop and commercialize therapies to restore movement and function after spinal cord injury (SCI). His talk will cover use of the company’s ARC-IM Therapy to restore movement in conjunction with an implanted brain-computer interface (BCI). It will also cover therapies that are expected to reach the clinic in the near term, such as the company’s ARC-EX Therapy which delivers transcutaneous electrical spinal cord stimulation to restore upper extremity strength and function, and the company’s standalone ARC-IM Therapy which is being evaluated for its ability to address blood pressure dysregulation after SCI. Mr. Marver will discuss the company’s ability to scale and bring these novel therapies into the clinic while also discussing the challenges associated with building an enterprise that is focused on therapies for SCI.

Dave Marver is CEO of ONWARD Medical N.V. (Euronext: ONWD), which is developing breakthrough therapies for people with spinal cord injury.

Dave spent almost 15 years with Medtronic in a variety of leadership positions around the world. Later, he served as CEO of Cardiac Science Corporation, a NASDAQ-listed company with 600 employees. He then founded and ran a high-profile sports technology start-up, raising $90M and developing two TIME Magazine Inventions of the Year.

Dave has been an advisor to the World Bank’s International Finance Group and a member of the Health Industry Distributors Association Board of Directors and Duke University’s Health Sector Advisory Council.